News articles for Cambrex Corporation:
Tuesday, February 11, 2014
Friday, February 7, 2014
Monday, December 16, 2013
Cambrex Manufacturing Facility Completes Successful US FDA Inspection
EAST RUTHERFORD, N.J., Dec. 16, 2013 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") announced that the US Food and Drug Administration (FDA) completed an inspection of Cambrex's active pharmaceutical ingredient (API) manufacturing facility in Charles City, Iowa. The inspection found the site to be compliant with the ... read more
Wednesday, December 4, 2013
Cambrex to Present at Oppenheimer 24th Annual Healthcare Conference
EAST RUTHERFORD, N.J., Dec. 4, 2013 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that Steven Klosk, President and Chief Executive Officer, will make a presentation on the Company at the Oppenheimer 24(th) Annual Healthcare Conference on December 10, 2013 at 4:30 p.m. EST, ... read more
Friday, November 1, 2013
Cambrex Reports Third Quarter 2013 Financial Results
EAST RUTHERFORD, N.J., Nov. 1, 2013 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM) reports results for the third quarter ended September 30, 2013.
-- Third quarter sales increased to $78.0 million from $59.8 million in the
third quarter of 2012.
... read more
Wednesday, October 30, 2013